Odne develops a Root Preservation Therapy (RPT) technology platform that introduces three medical devices for minimally invasive root canal cleaning and light-cured obturation. Its platform includes the first hydro-dynamic cavitation device using saline for debridement and an FDA-cleared highly flowable, light-cured obturation material. Odne received FDA clearance for Odne™Cure and Odne™Fill in 2023 and plans product launches in 2024. To support US market entry the company has founded Odne Inc, USA, is running a Priority Access Program with US key opinion leaders, and will introduce the RPT workflow at the American Association of Endodontists meeting. The team is expanding to build training, service, marketing, and sales capabilities for the endodontic specialist market. Financially, Odne closed a $5.5M Series A1 round to fund its US market launch.

Total raised

$9M

Funding rounds

3

Latest round

Series A

Latest activity

Mar 2024